Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› St Albans
Clinical trial register · Australia

Clinical Trials in St Albans, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 Hoffmann-La Roche7 Pfizer5 Takeda2 Merck Sharp & Dohme LLC2
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in St Albans

50 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
AstraZeneca
Phase 3
2,500
Botany, Kotara, Malvern, St Albans, St Leonards, Waitara
2026-08-19
Recruiting
AstraZeneca
Phase 3
915
Auchenflower, Ballarat, Clayton, Darlinghurst, Elizabeth Vale, South Brisbane, St Albans
2026-07-16
Recruiting
Pfizer
Phase 2
120
St Albans
2026-06-30
Recruiting
AstraZeneca
Phase 3
4,500
Botany, Camberwell, Charlestown, Maroubra, St Albans, St Leonards
2026-06-29
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Blacktown, Macquarie Park, Clayton, Geelong, Melbourne, St Albans, Perth
2026-05-21
Recruiting
AstraZeneca
Phase 1
40
Fitzroy, St Albans, Woolloongabba
2026-03-31
Recruiting
Takeda
Phase 3
183
Kogarah, Douglas, Greenslopes, Adelaide, St Albans, Murdoch, Melbourne
2026-01-14
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans
2025-12-12
Recruiting
AbbVie
Phase 2/3
490
Garran, Kogarah, South Brisbane, Hobart, Fitzroy, St Albans, Nedlands
2025-12-10
Recruiting
AstraZeneca
Phase 3
400
Gosford, Kogarah, South Brisbane, St Albans, Wollongong
2025-10-31
Recruiting
Pfizer
Phase 2/3
982
Nowra, Westmead, Kurralta Park, Hobart, St Albans
2025-10-03
Recruiting
Pfizer
Phase 3
400
Kurralta Park, Melbourne, St Albans
2025-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Wollongong, Birtinya, Clayton, St Albans
2025-07-16
Recruiting
Takeda
Phase 3
347
Liverpool, Milton, Box Hill, Clayton, St Albans
2025-07-15
Active, closed
Pfizer
Phase 1/2
74
Blacktown, Brisbane, St Albans
2025-06-30
Recruiting
BeOne Medicines
Phase 1
120
Darlinghurst, Waratah, Birtinya, Melbourne, St Albans, Nedlands
2025-02-04
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Concord, Heidelberg, South Woodville, St Albans
2024-12-12
Recruiting
Novo Nordisk A/S
Phase 2
465
Castle Hill, Gosford, Chelmer, Reservoir, St Albans
2024-12-02
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Albury, Bedford Park, St Albans, Traralgon
2024-08-07
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease, Primary Immunoglobulin A Nephropathy
Walden Biosciences
Phase 2
96
Westmead, St Albans
2024-07-02
Active, closed
Amgen
Phase 1
120
Camperdown, St Leonards, Woodville South, Heidelberg, Melbourne, St Albans
2024-05-29
Recruiting
Daiichi Sankyo
Phase 3
540
Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
2024-05-21
Recruiting
CSL Behring
Phase 2/3
3,110
Saint Leonards, Sydney, Cairns, Nambour, Woolloongabba, Clayton, St Albans, Bundaberg
2024-04-27
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Canberra, Clayton, Concord, Herston, Liverpool, Perth, Southport, St Albans
2024-03-29
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Frenchs Forest, Kingswood, North Sydney, Buderim, South Brisbane, Adelaide, Geelong, St Albans
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 3
459
Kingswood, Kogarah, Liverpool, Woolloongabba, Adelaide, Parkville, St Albans
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 2
83
St Albans
2023-07-18
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Gosford, Kogarah, Liverpool, Penrith, St Leonards, Cairns North, Box Hill, St Albans
2023-07-06
Active, closed
OncoC4, Inc.
Phase 3
630
Bankstown, Newstead, Adelaide, St Albans
2023-06-28
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Coffs Harbour, Macquarie University, New Lambton Heights, St Leonards, Chermside, Adelaide, St Albans, Nedlands
2022-12-05
Recruiting
Monash University
Phase 2/3
300
Garran, Concord, St Leonards, Clayton, Heidelberg, Melbourne, St Albans
2022-11-30
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Nedlands, St Albans, West Perth
2022-07-22
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
East Melbourne, Albury, Sydney, Bendigo, St Albans
2022-06-30
Active, closed
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
NCT05355298Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma
Amplia Therapeutics Limited
Phase 1/2
62
St Leonards, Waratah, Westmead, Greenslopes, Box Hill, Clayton, Richmond, St Albans
2022-05-31
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Garran, Concord, Kogarah, New Lambton Heights, Saint Leonards, Adelaide, Fitzroy, St Albans
2022-04-05
Active, closed
AstraZeneca
Phase 3
1,051
Box Hill, East Melbourne, Elizabeth Vale, Gosford, Heidelberg, Kogarah, South Brisbane, St Albans
2022-02-07
Active, closed
Incyte Corporation
Phase 3
654
Kogarah, Sydney, Wollongong, Southport, Adelaide, Bedford Park, Melbourne, St Albans
2021-04-15
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Bendigo, Concord, Fitzroy, Gosford, Kurralta Park, Melbourne, St Albans, Sydney
2021-03-18
Active, closed
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease
DrugAtrasentan
Novartis Pharmaceuticals
Phase 2
103
Gosford, Herston, Clayton, Reservoir, St Albans, St Leonards
2021-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Campbelltown, Kingswood, Waratah, Southport, Frankston, Heidelberg, St Albans
2020-12-08
Active, closed
Hoffmann-La Roche
Phase 2
303
Darlinghurst, St Albans
2020-11-27
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Active, closed
Hoffmann-La Roche
Phase 3
992
Waratah, South Brisbane, Woolloongabba, Melbourne, St Albans, Murdoch
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Geelong, St Albans
2020-09-03
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Sydney, Brisbane, Adelaide, Melbourne, Richmon, St Albans, Perth
2020-03-01
Active, closed
AstraZeneca
Phase 3
895
Box Hill, Darlinghurst, Greenslopes, Herston, Kingswood, Kurralta Park, St Albans, Waratah
2018-10-31
Active, closed
AstraZeneca
Phase 3
1,246
Box Hill, Elizabeth Vale, Kogarah, Macquarie University, Murdoch, Orange, South Brisbane, St Albans
2018-09-27
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Albury, Camperdown, Gosford, North Ryde, Randwick, St Albans
2017-09-05
Active, closed
Eisai Inc.
Phase 3
1,069
Box Hill, Heidelberg, Hobart, Macquarie Park, South Brisbane, St Albans
2016-10-13
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/st-albans

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in St Albans.

How many clinical trials are recruiting in St Albans?

25 of the 50 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (St Albans), 50 studies
PhaseStudiesRecruitingShare
Phase 3281356%
Phase 27414%
Phase 2/36512%
Phase 1428%
Phase 1/2408%
Not applicable112%

Most active sponsors

Lead sponsors with the most studies (St Albans)
Lead sponsorStudiesRecruiting
AstraZeneca85
Hoffmann-La Roche71
Pfizer54
Merck Sharp & Dohme LLC21
Novartis Pharmaceuticals20
Takeda22
AbbVie11
Alexion Pharmaceuticals, Inc.10
Amgen10
Amplia Therapeutics Limited10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.